Capabilities

Standardized methods. Comparable results.

Every batch follows the same SOPs and outputs the same report structure — so vendors and customers can compare apples to apples.

HPLC purity resolution

0.01%

Mass accuracy

±0.1 Da

Concentration

<2% CV

Endotoxin alignment

USP <85>

Reverse-phase HPLC quantifies peptide purity to 0.01% with UV detection across configurable gradients.

Detection: 214 nm · LOQ: 0.05%

Liquid chromatography paired with mass spectrometry to confirm molecular weight against the expected target.

Mass accuracy: ±0.1 Da

Quantitative concentration verification using calibrated reference standards. Reported in mg/vial.

Range: 0.1–50 mg · CV < 2%

Cross-method confirmation combining retention time matching with mass spectral fingerprinting.

Dual-method confirmation

Optional endotoxin screening (LAL) and sterility verification for injectable-grade product workflows.

USP <85> aligned

Bespoke methods for novel peptides, conjugates, and complex matrices. Method development included.

Method dev: 2–3 weeks